Mar 31, 2012

Neurocrine Biosciences Q1 2012 Earnings Report

Total Revenue
$11.3M
Previous year: $12.5M
-10.0%
EPS
-$0.01
Previous year: $0.05
-120.0%
Gross Profit
$11.3M
Previous year: $12.5M
-10.0%
Cash and Equivalents
$76.9M
Previous year: $24.4M
+215.4%
Free Cash Flow
-$11.6M
Previous year: -$8.6M
+35.0%
Total Assets
$210M

Neurocrine Biosciences

Neurocrine Biosciences